Kezar Life Sciences reports 2022 annual meeting voting results

Kezar Life Sciences, Inc.

Stockholders elected Elizabeth Garner, Michael Kauffman, and Courtney Wallace as Class I directors until 2025.
Garner received 32,387,898 votes for; Kauffman 29,866,607; Wallace 45,460,015.
Ratification of KPMG as independent auditor for FY2022 passed with 56,166,095 for, 12,016 against, 1,946 abstain.
No other proposals were voted on; all nominees and auditor ratified.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.